BUSINESS

• Astellas to Transfer Manufacturing Plant in Netherlands to French Firm
  May 26, 2023

• Clinical Trial Notification Filed for RPE Tear Cell Therapy: Sumitomo/Healios
  May 26, 2023

• GSK’s Pediatric Antibiotic Clavamox to Be Out of Stock on Demand Spike
  May 25, 2023

• Some 400 General Employees Likely Leaving Bayer under Redundancy Program
  May 25, 2023

• Lilly’s Omvoh Launch Set for June 21; BioMarin’s Palynziq Now Available
  May 25, 2023

• Novartis Japan Rolling Out New Operational Model Tailored to Local Needs: President
  May 24, 2023

• Mitsubishi Tanabe to Refine Growth Scenario, Expand Overseas Operations under New Leadership
  May 24, 2023

• Oncodesign, Veritas Form Collab for mRNA Drug Development
  May 24, 2023

• Lecanemab Filed in UK, Designated under Innovative Pathway: Eisai/Biogen
  May 23, 2023

• Sawai and Towa Profits Tank 50% on Flat Sales in Japan: FY2022 Earnings
  May 22, 2023

• Astellas CEO Confident about Veozah Uptake, 500 Billion Yen Sales Potential
  May 22, 2023

• Mounjaro No. 1 in GP Promotion in March, Dayvigo Most Detailed for HPs
  May 22, 2023

• Nipro’s Nexium AG Grabs 53% Market Share in Just 4 Months
  May 22, 2023

• Daiichi Sankyo Begins Japan PIII for Omicron-Tailored Jab
  May 22, 2023

• Top 4 Wholesalers on Solid Note with 30% Operating Profit Rise in FY2022
  May 19, 2023

• Taiho Seals Trial Pact for Arcus Oncology Meds to Work with Gilead
  May 19, 2023

• Qol to Further Expand Espha's AG Biz, Eyes Biosame Territory: Exec
  May 19, 2023

• BMS Files Luspatercept for MDS Associated Anemia in Japan
  May 19, 2023

• Lecanemab’s Social Value in Japan Simulated at 4.7 Million Yen per Patient/Year: Eisai
  May 18, 2023

• Xocova Makes Up 11% of COVID Oral Drug Prescriptions Filled Outside Pharmacies
  May 18, 2023

ページ

• « 先頭
• ‹ Prev
• …
• 144
• 145
• 146
• 147
• 148
• 149
• 150
• 151
• 152
• …
• Next ›
• 最終 »